Sybil Danby

Sybil Danby currently serves as the General Manager of Cell Lines and Global Commercial Leader for Viral Vector at Cytiva since May 2023. Prior to this, Sybil held the position of Business Development and Strategy at the Center for Breakthrough Medicines from August 2020 to May 2023. Sybil's experience includes serving as Senior Director of Business Development at Paragon Bioservices, Inc. from August 2016 to January 2020 and as Sales Manager for Cell Culture Technologies at Pall Corporation from September 2014 to August 2016. Sybil began a career in the biopharmaceutical field at GSK, working as both a Senior Scientist and Biopharmaceutical Manufacturing Associate between February 2006 and September 2014. Sybil holds a Master's degree in Biology from West Chester University of Pennsylvania (2010-2014) and a Bachelor's degree in Biology from the University of Rochester (2001-2005).